CHSPR Seminar | Towards Digital Twinning of Cancer Patients in Medicine, and Tackling Barriers to Clinical Adoption

Arman Rahmim, University of BC and BC Cancer

Tuesday, Feb 24, 2026
12-1 pm PT
SPPH or Zoom (Arman Rahmim will speak in person)
Register

This talk will focus on the emerging paradigm of digital twinning of cancer patients and application of virtual therapies for identification of optimal therapies, moving towards personalization of treatments. The talk will particularly focus on the exciting paradigm of theranostics, and also discuss the role of AI and efforts performed (and in need of being performed in the future) to identify and tackle barriers to adoption of such advanced tools in the clinic.

Arman Rahmim is a professor of radiology, physics and biomedical engineering at UBC, as well as a Distinguished Scientist at BC Cancer. His laboratory (Qurit Lab) pursues research in molecular imaging and therapy. He also hosts the Molecular Imaging & Therapy YouTube channel to help disseminate learning for a wide audience including students, residents, fellows and technologists. He is Scientific Lead of the BC Cancer Medical Imaging Core (CanMIC) Lab, aiming to translate state-of-the-art imaging solutions to clinical trials and research.

Register in advance for this seminar. After registering, you will receive a confirmation email containing information about joining the meeting.